Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia

Qiqi Mao(First Affiliated Hospital Zhejiang University), Liping Xie(First Affiliated Hospital Zhejiang University), Xiaolong Jia(Ningbo University Affiliated Hospital), Kai Yang(First Affiliated Hospital Zhejiang University), Yu Bai(First Affiliated Hospital Zhejiang University), Yuyong Wang(First Affiliated Hospital Zhejiang University), Jie Qin(Sun Yat-sen University), Xiangyi Zheng(Tianjin University)
International Urology and Nephrology
February 17, 2009
10.1007/s11255-009-9533-1
Cited by 25

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188